RM-1490, a novel MOR agonist as maintenance therapeutic in opioid use disorder Nov. 2, 2021 No Comments
Aileron Therapeutics' ALRN-6924 shows preclinical activity against acute radiation injury Oct. 8, 2021 No Comments
NIDA agrees to screen Initiator Pharma's preclinical assets for anti-addictive properties Sep. 20, 2021 No Comments
Opiant reports topline data from confirmatory PK study of OPNT-003 for opioid overdose July 7, 2021 No Comments
RSS